Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 23, 2007. The report details a share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 17, 2006.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the share repurchase price of 1,355.79 pence per share.
Material Changes
- Share Repurchase: The Company purchased 1,835,000 Ordinary shares of 25 pence each on May 23, 2007.
- Treasury Holdings: Following the transaction, the Company holds 299,532,678 shares in Treasury, representing 4.98% of total voting rights.
- Shares in Issue: The total number of shares in issue (excluding Treasury shares) is 5,720,714,642.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Points
- Verify the total Treasury share count of 299,532,678 and its 4.98% ownership stake.
- Confirm the total shares in issue of 5,720,714,642 for disclosure threshold calculations.
- Note that this filing is a regulatory notification of a capital action and does not contain operational or financial performance results.